Article
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA
8 Oct 2024
Abstract excerpt
Influenza viruses cause substantial morbidity and mortality every year despite seasonal vaccination. mRNA-based vaccines have the potential to elicit more protective immune responses, but for maximal breadth and durability, it is desirable to deliver both the viral hemagglutinin and neuraminidase glycoproteins. Delivering multiple antigens individually, however, complicates manufacturing and increases cost, thus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
